Candel Therapeutics said it is advancing an investigational viral immunotherapy for localized prostate cancer. The update follows new data on candidates aglatim

BWB News TV • 2026-11-10 15:07 UTC • By Billy Odell Tucker-Robinson

Candel Therapeutics said it is advancing an investigational viral immunotherapy for localized prostate cancer. The update follows new data on candidates aglatimagene and linoserpaturev presented at SITC26.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly